HomeOculocare medical Inc.

Oculocare medical Inc.

Oculocare’s Alleye® Receives FDA 510(k) Clearance for Monitoring Eyesight in AMD

7/9/18: Alleye is designed to detect and characterize central and paracentral metamorphopsia (visual distortion) in patients with macular conditions including AMD and diabetic retinopathy. After medical diagnosis by an eye specialist, the mobile application Alleye lets patients regularly perform simple self-tests at home to monitor their eyesight and/or assess disease progression.